CorVel Corporation — Form 10-Q Summary
Period clarification: The supplied filing is for the quarter ended December 31, 2011, filed February 3, 2012. This conflicts with the request metadata stating “2010 Q3.” Comparisons below are against the quarter and nine months ended December 31, 2010.
Business context and reporting period
CorVel provides workers’ compensation managed-care services, principally Network Solutions and Patient Management, to insurers, employers, third-party administrators and government agencies. It reports one operating segment. Results are unaudited.
Financial performance
| Metric | Quarter ended Dec. 31, 2011 | Year-over-year change | Nine months ended Dec. 31, 2011 | Year-over-year change |
|---|---|---|---|---|
| Revenue | $101.4 million | +6.4% | $308.2 million | +10.0% |
| Gross profit / margin | $21.2 million / 20.9% | -$2.6 million; margin down from 25.0% | $72.4 million / 23.5% | +$1.5 million; margin down from 25.3% |
| Income before taxes | $8.9 million | -22.0%; 8.8% of revenue | $35.2 million | +7.3%; 11.4% of revenue |
| Net income | $5.4 million | -19.7% | $21.5 million | -2.4% |
| Diluted EPS | $0.47 | Down from $0.56 | $1.84 | Up from $1.82 |
| Operating cash flow | Not separately presented | — | $28.0 million | Down from $38.2 million |
Quarterly Patient Management revenue rose 10.5% to $49.1 million, while Network Solutions grew 2.8% to $52.3 million. For the nine-month period, the respective increases were 11.4% to $146.8 million and 8.8% to $161.4 million.
At December 31, cash and cash equivalents were $10.1 million; current assets were $77.6 million and current liabilities $46.6 million, giving working capital of approximately $31.0 million. CorVel had no debt outstanding and had a $10 million revolving credit facility; $8 million of letters of credit were issued separately from that facility. Nine-month capital expenditures were $16.7 million. The filing reports no debt-related market risk.
Material changes and management commentary
- Quarterly revenue growth did not translate into higher profit: cost of revenue increased 12.2%, faster than revenue, and gross profit fell 10.9%. Management attributed margin pressure to a mix shift toward lower-margin, more labor-intensive Patient Management work and lower-margin Network Solutions services, as well as $1.1 million in higher fringe-benefit costs, primarily medical-plan costs.
- For the nine months, cost of revenue rose 12.7%, also faster than revenue. General and administrative expense declined 2.3% to $37.2 million; as a share of revenue it fell to 12.1% from 13.6%.
- The nine-month operating-cash-flow decline primarily reflected the $9 million litigation settlement payment deposited into escrow. Investing cash use was $16.8 million, mainly reflecting higher software development and capitalization. Financing cash use included $16.3 million of share repurchases.
- CorVel repurchased 348,593 shares for $16.3 million during the nine months. After quarter-end, it repurchased 37,794 shares for $1.92 million and its board increased the program authorization from 15 million to 16 million shares.
Outlook, risks, contingencies and unusual items
- Management said cash, operating cash generation and stock-option exercises should be adequate for obligations, planned repurchases, new services and healthcare-business development for at least 12 months. The company expected to renew its revolving facility when it expires in September 2012. No specific revenue or earnings guidance was provided.
- Management cautioned that Patient Management referrals and Network Solutions bill-review volumes may remain weak or grow only modestly until workers’ compensation injuries and claims increase. The filing also identifies competition, customer insourcing or termination, regulatory changes, litigation, staffing and benefit costs, and technology, data-security and system-continuity risks.
- The Louisiana class-action settlement was for $9 million, previously charged to earnings in the March 2011 quarter and paid into escrow in July 2011. Final court approval was granted November 4, 2011; the judgment became final January 17, 2012, and CorVel said it had begun seeking dismissal of covered claims. The settlement was not an admission of liability.
- The Illinois class-action settlement was accrued at $2.8 million in 2010. A modified final judgment in January 2012 did not change its financial terms; remaining payments were expected to be completed by July 2012. Management said other ordinary-course litigation was not expected to be material in aggregate.
- Contractual obligations totaled $50.6 million, principally operating leases of $48.2 million. Management noted estimates and assumptions in areas including revenue recognition, receivable allowances, self-insurance reserves, taxes, share-based compensation and loss contingencies.
Important facts for investors to verify
- Confirm the intended reporting period: the filing covers the quarter ended December 31, 2011, not “2010 Q3.”
- Track whether service mix, medical-plan costs and other cost pressures continue to weigh on gross margin and quarterly earnings.
- Review subsequent filings for renewal of the credit facility, compliance with its covenants and cash availability after repurchases and contractual commitments.
- Confirm completion of Louisiana settlement-related dismissals and the remaining Illinois settlement payments.
- Assess whether claim volumes, customer utilization and outsourcing trends support continued revenue growth, and monitor the company’s stated operational, regulatory, litigation and systems risks.